Ross Feldman, MD
RW Gunton Professor of Therapeutics, Departments of Medicine and of Physiology & Pharmacology The University of Western Ontario
Scientist, Vascular Biology Group Robarts Research Institute

Dr. Ross Feldman is the R.W. Gunton Professor of Therapeutics, Departments of Medicine (and of Pharmacology and Physiology) at the University of Western Ontario and the Deputy Scientific Director of the Robarts Research Institute.
Dr. Feldman received his medical degree from the Queen's University in Kingston, Ontario in 1977 and training in Internal Medicine (University of Toronto) and Clinical Pharmacology (Vanderbilt University). Following his postgraduate training, he has held teaching positions at the University of Iowa College of Medicine in Iowa City and then at the University of Western Ontario (since 1989).
Among a number of awards and scholarships, Dr. Feldman was the recipient of a Career Investigator Award (Heart and Stroke Foundation of Ontario), the George Morris Piersol Research and Teaching Scholarship from the American College of Physicians and the Burroughs-Wellcome Clinical Pharmacology Award and in 2006 received both the Senior Investigator Award from the Canadian Society for Clinical Pharmacology and the Distinguished Service Award of the Canadian Hypertension Society. He has recently been named as the editor of the journal Pharmacological Reviews. He is the Associate Editor of the Canadian Journal of Cardiology and the Canadian Journal of Physiology and Pharmacology. He is a member of the editorial boards for several other journals including Clinical Pharmacology and Therapeutics and American Journal of Physiology. He is the author of more than 100 original manuscripts, in the fields of cell signaling, adrenergic pharmacology and management of hypertension. His clinical research focuses on the study of techniques to improve blood pressure control. His "wet lab" research focuses on elucidating receptor-mediated mechanisms of vasoreactivity and how these mechanisms are regulated.
He has taken leadership roles in a number of scientific and professional organizations in the disciplines of pharmacology, clinical pharmacology and hypertension. He has been Vice-President of the American Society of Clinical Pharmacology and Therapeutics, Chair of the Clinical Pharmacology Division of the American Society of Pharmacology and Experimental Therapeutics as well as President of the Canadian Hypertension Society.
A major focus of his efforts has been in the knowledge translation of optimal treatment approaches in the management of hypertension. In 2005, Dr. Feldman completed his term as founding Chair of the Steering Committee of the Canadian Hypertension Education Program which, since 1999 has produced a disseminated yearly updates of the Canadian Recommendations for the Management of Hypertension.